Mark Slevin
Impact in
- Neurology top 1%
- Neuroinflammation and Neurodegeneration Mechanisms
- Cell Biology top 1%
- Proteoglycans and glycosaminoglycans research
Papers in
-
- Angiogenesis and VEGF in Cancer 26
- Neurology 33
- Neuroinflammation and Neurodegeneration Mechanisms 21
- Co-authors
- John Gaffney (36 shared papers)Jerzy Krupiński (58 shared papers)Shant Kumar (24 shared papers)Lina Badimón (30 shared papers)Nessar Ahmed (14 shared papers)Pat Kumar (11 shared papers)S. Kumar (7 shared papers)Sabine Matou (6 shared papers)
- Journals
- British Journal of Cancer (16 papers)International Journal of Molecular Sciences (12 papers)Frontiers in Immunology (8 papers)Scientific Reports (6 papers)Stroke (5 papers)
- Partner nations
- United KingdomSpainRomania
In The Last Decade
Mark Slevin
224 papers receiving 7.5k citations
Mark Slevin's Hit Papers
Peers
Comparison fields: 5 of 146
- Neurology 767
- Cell Biology 786
- Biological Psychiatry 97
- Developmental Neuroscience 163
- Cancer Research 499
Countries citing papers authored by Mark Slevin
This map shows the geographic impact of Mark Slevin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Slevin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Slevin more than expected).
Fields of papers citing papers by Mark Slevin
This network shows the impact of papers produced by Mark Slevin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Slevin. The network helps show where Mark Slevin may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Slevin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 235 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin Hit paper breakdown → | 1996 | 611 |
| 2 | 2006 | 384 | |
| 3 | 2002 | 306 | |
| 4 | 1992 | 239 | |
| 5 | 2018 | 229 | |
| 6 | 2000 | 204 | |
| 7 | Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. | 1998 | 168 |
| 8 | 1997 | 144 | |
| 9 | 2006 | 125 | |
| 10 | 2008 | 125 | |
| 11 | 1998 | 108 | |
| 12 | 2015 | 104 | |
| 13 | 2009 | 102 | |
| 14 | 2023 | 100 | |
| 15 | 1995 | 100 | |
| 16 | 2008 | 99 | |
| 17 | 2017 | 98 | |
| 18 | 2013 | 94 | |
| 19 | 2009 | 88 | |
| 20 | 2010 | 84 |
About Mark Slevin
Mark Slevin is a scholar working on Molecular Biology, Neurology, Surgery, Oncology and Epidemiology, having authored 235 papers that have together received 7.8k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (26 papers), Neuroinflammation and Neurodegeneration Mechanisms (21 papers), Adipokines, Inflammation, and Metabolic Diseases (15 papers), Protease and Inhibitor Mechanisms (12 papers), Cell Adhesion Molecules Research (11 papers), Alzheimer's disease research and treatments (11 papers), Atherosclerosis and Cardiovascular Diseases (11 papers) and Mesenchymal stem cell research (9 papers). The work is most often cited by research in Neurology (767 citations), Cell Biology (786 citations), Biological Psychiatry (97 citations), Developmental Neuroscience (163 citations) and Cancer Research (499 citations). Mark Slevin has collaborated with scholars based in United Kingdom, Spain and Romania. Frequent co-authors include John Gaffney, Jerzy Krupiński, Shant Kumar, Lina Badimón, Nessar Ahmed, Pat Kumar, S. Kumar, Sabine Matou, David C. West and Patricia Kumar. Their work appears in journals such as British Journal of Cancer, International Journal of Molecular Sciences, Frontiers in Immunology, Scientific Reports and Stroke.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.